Skip to main content
VIP Research

Udupa 2025 — Aviptadil Therapy in ARDS Systematic Review and Meta-Analysis

Journal of Intensive Care Medicine·January 1, 2025

A. A. Udupa, et al.

Summary

Systematic review evaluating whether aviptadil improves survival and oxygenation outcomes in ARDS. Useful for presenting VIP/aviptadil as investigational rather than proven.

Study Details
Study Design

Systematic review and meta-analysis

Indication

Acute respiratory distress syndrome

Intervention

Aviptadil / vasoactive intestinal peptide

Species

Human

Risk of Bias Assessment

Meta-analysis; limited underlying trial base

Tags
SourceSystematic ReviewVipAviptadilArdsRespiratory FailureInvestigational
External Links
Metrics
Citations
1
Evidence QualityN/A
Last VerifiedMay 9, 2026
Related PeptideVIP2 papers